Anjali Sibley is an Oncology physician affiliated with Palo Alto University. OpenAlex indexes 9 publications with 338 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 16 Apr 2024.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Celgene CorporationProgram year20255 payments
- ARRAY BIOPHARMA INCProgram year20252 payments
- Astellas Pharma US IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
23.7%Factor Xa inhibitor23.7%Eliquis91%Xarelto9%Part D<11 patientsMetabolism & gastrointestinal
20.2%Serotonin-3 Receptor Antagonist8%Ondansetron Hcl74%Ondansetron Odt26%Part D<11 patientsAntidiarrheal microorganisms3.7%Folic Acid100%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
15.1%Aromatase Inhibitor12.1%Anastrozole37%Exemestane37%Letrozole26%Part D<11 patientsAntimetabolite3%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- QIM25-226: What Patients Anticipate About Working Out with Cancer: Qualitative Survey Results
Journal of the National Comprehensive Cancer Network
2025 - Using Patient-Related Outcomes Data to Inform About a Novel Exercise Program in Oncology Patients
Journal of Cancer Education
2024 - Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 3
Journal of Viral Hepatitis
2015 - Strategies to manage hepatitis C virus infection disease burden – volume 3
Journal of Viral Hepatitis
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Tait Shanafelt, MD
Palo Alto University
Victor Froelicher, MD
Palo Alto University
Kimford Meador, MD
Palo Alto University
Michael Marmor, MD
Palo Alto University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”